Clinical Scorecard: Assessment of Continuous Veno-Venous Hemofiltration's Safety and Effectiveness in Acute Respiratory Distress Syndrome: A Meta-Analytic Review
At a Glance
Category
Detail
Condition
Acute Respiratory Distress Syndrome (ARDS)
Key Mechanisms
Continuous veno-venous hemofiltration (CVVH) improves solute removal and reduces inflammation.
Target Population
Patients with acute respiratory distress syndrome (ARDS).
Care Setting
Critical care settings, specifically in intensive care units (ICUs).
Key Highlights
CVVH improves oxygenation index and reduces mortality in ARDS patients.
Significant reductions in ICU and mechanical ventilation duration with CVVH.
CVVH lowers inflammatory markers such as TNF-α and IL-6.
Guideline-Based Recommendations
Diagnosis
ARDS diagnosis based on clinical criteria including refractory hypoxemia.
Management
Use CVVH as an adjunctive therapy for ARDS to improve outcomes.
Monitoring & Follow-up
Monitor oxygenation, inflammatory markers, and hemodynamic parameters.
Risks
Potential for substantial heterogeneity and publication bias in studies.
Patient & Prescribing Data
1,739 patients from 28 randomized controlled trials.
CVVH demonstrated superior outcomes compared to conventional treatment.
Clinical Best Practices
Consider CVVH for patients with severe ARDS to enhance oxygenation and reduce mortality.
Regularly assess and adjust treatment protocols based on patient response.
Researchers analyzed UK Biobank data to determine whether spending sedentary time in prolonged vs interrupted bouts was associated with subsequent cancer incidence and cancer mortality.
